|
Current and recommended treatment in patients with confirmed COPD and proportion of patients in whom a treatment was recommended who were receiving that treatment |
|||
| No. currently receiving the treatment |
No. for whom the treatment was recommended |
No. receiving the treatment recommended for them |
|
| (N = 278) |
(N = 278) |
(N = 278) |
|
|
|
|||
| SAAC |
124 (44.6%) |
109 (39.2%) |
59/109 (54%) |
| LAB2 agonists |
124 (44.6%) |
80 (28.8%) |
37/80 (46%) |
| LAAC |
50 (18.0%) |
53 (19.1%) |
12/53 (23%) |
| Inhaled steroids |
167 (60.0%) |
48 (17.0%) |
39/48 (81%) |
| Mucolytics |
9 (3%) |
144 (53.0%) |
6/144 (4%) |
Jones et al. Respiratory Research 2008 9:62 doi:10.1186/1465-9921-9-62 |
|||